Bright Eye Hospital Group Co., Ltd. (SHE:301239)
China · Delayed Price · Currency is CNY 43.94
-0.54 (-1.21%)
At close: May 8, 2026
Bright Eye Hospital Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 2,875 | 2,767 | 2,660 | 2,705 | 1,715 | 1,703 |
Other Revenue | - | 30.18 | 18.59 | 12.79 | 11.09 | 7.4 |
| 2,875 | 2,797 | 2,678 | 2,718 | 1,726 | 1,710 | |
Revenue Growth (YoY) | 4.76% | 4.44% | -1.46% | 57.50% | 0.91% | 25.54% |
Cost of Revenue | 1,826 | 1,659 | 1,561 | 1,424 | 927.51 | 903.36 |
Gross Profit | 1,050 | 1,139 | 1,117 | 1,294 | 798.13 | 806.66 |
Selling, General & Admin | 850.54 | 985.18 | 1,012 | 913.35 | 694.23 | 627.16 |
Research & Development | 10.8 | 10.82 | 8.02 | 11.03 | 6.64 | - |
Other Operating Expenses | 3.19 | 5.33 | 8.12 | 5.89 | 3.19 | 2.67 |
Operating Expenses | 864.52 | 1,003 | 1,028 | 933.65 | 705.65 | 629.83 |
Operating Income | 185.14 | 136.01 | 88.92 | 360.37 | 92.47 | 176.83 |
Interest Expense | - | -19.33 | -16.97 | -74.67 | -57.56 | -48.44 |
Interest & Investment Income | - | 4.2 | 8.54 | 95.35 | 29.54 | 13.75 |
Currency Exchange Gain (Loss) | - | -0.01 | -0.05 | -0.41 | -0.01 | - |
Other Non Operating Income (Expenses) | -108.73 | -73.71 | -77.67 | -31.69 | -13.59 | -5.87 |
EBT Excluding Unusual Items | 76.38 | 47.16 | 2.78 | 348.96 | 50.84 | 136.27 |
Impairment of Goodwill | - | -7.69 | -4.54 | - | -1.64 | -8.12 |
Gain (Loss) on Sale of Investments | -11.31 | -10.17 | -3.51 | 0.1 | - | - |
Gain (Loss) on Sale of Assets | -0.13 | 0 | -0.93 | 0.06 | 0.56 | 0.93 |
Asset Writedown | -11.8 | -1.1 | -1.46 | -0.47 | -0.47 | -0.5 |
Other Unusual Items | - | -15.69 | -18.36 | 13.58 | 9.94 | 10.33 |
Pretax Income | 53.14 | 12.52 | -26.02 | 362.23 | 59.23 | 138.9 |
Income Tax Expense | 62.64 | 66.23 | 66.81 | 84.23 | 38.66 | 45.01 |
Earnings From Continuing Operations | -9.5 | -53.72 | -92.83 | 278.01 | 20.57 | 93.89 |
Minority Interest in Earnings | -8.06 | -7.2 | -9.03 | -10.09 | - | - |
Net Income | -17.56 | -60.92 | -101.86 | 267.91 | 20.57 | 93.89 |
Net Income to Common | -17.56 | -60.92 | -101.86 | 267.91 | 20.57 | 93.89 |
Net Income Growth | - | - | - | 1202.56% | -78.09% | -13.81% |
Shares Outstanding (Basic) | 148 | 149 | 150 | 150 | 129 | 112 |
Shares Outstanding (Diluted) | 148 | 149 | 150 | 150 | 129 | 112 |
Shares Change (YoY) | -0.63% | -0.80% | 0.08% | 16.43% | 15.01% | -0.39% |
EPS (Basic) | -0.12 | -0.41 | -0.68 | 1.79 | 0.16 | 0.84 |
EPS (Diluted) | -0.12 | -0.41 | -0.68 | 1.79 | 0.16 | 0.84 |
EPS Growth | - | - | - | 1018.75% | -80.95% | -13.40% |
Free Cash Flow | 321.79 | 318.45 | -160.43 | -12.41 | -8.68 | 104.62 |
Free Cash Flow Per Share | 2.17 | 2.14 | -1.07 | -0.08 | -0.07 | 0.94 |
Dividend Per Share | - | - | - | 0.400 | 0.100 | - |
Dividend Growth | - | - | - | 300.00% | - | - |
Gross Margin | 36.50% | 40.71% | 41.70% | 47.61% | 46.25% | 47.17% |
Operating Margin | 6.44% | 4.86% | 3.32% | 13.26% | 5.36% | 10.34% |
Profit Margin | -0.61% | -2.18% | -3.80% | 9.86% | 1.19% | 5.49% |
Free Cash Flow Margin | 11.19% | 11.38% | -5.99% | -0.46% | -0.50% | 6.12% |
EBITDA | 338.51 | 278.86 | 213.26 | 451.57 | 162.32 | 232.68 |
EBITDA Margin | 11.77% | 9.97% | 7.96% | 16.61% | 9.41% | 13.61% |
D&A For EBITDA | 153.37 | 142.85 | 124.34 | 91.2 | 69.84 | 55.85 |
EBIT | 185.14 | 136.01 | 88.92 | 360.37 | 92.47 | 176.83 |
EBIT Margin | 6.44% | 4.86% | 3.32% | 13.26% | 5.36% | 10.34% |
Effective Tax Rate | 117.87% | 529.21% | - | 23.25% | 65.27% | 32.41% |
Revenue as Reported | - | 2,797 | 2,678 | 2,718 | 1,726 | 1,710 |
Advertising Expenses | - | 230.39 | 220.74 | 240.06 | 197.96 | 178.68 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.